FIELD: medicine, dermatology, phytotherapy. SUBSTANCE: invention relates to development of plant raw agents for treatment of patients with psoriasis. Agent has the following components: bur-marigold tripartite herb, cowberry leaves, sweet flag rhizome and roots, sage leaves, maize stigmas, common immortelle sandy flowers, milfoil herb, fennel fruits, thyme creeping herb, dandelion roots, violet tricolor herb, juniper fruits taken at the definite ratio. Proposed agent shows stable clinical effect in patients with different psoriasis forms. EFFECT: decreased time of treatment, prolonged remission, absence of any adverse effects. 1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF CHRONIC PYELONEPHRITIS | 2001 |
|
RU2224531C2 |
| AGENT FOR TREATMENT OF STOMACH AND DUODENUM ULCER DISEASE WITH ERADICATION OF HELICOBACTER PYLORI OCCURRING ON BACKGROUND OF LIVER CHRONIC DISEASES | 2004 |
|
RU2274467C2 |
| AGENT FOR TREATMENT OF PATIENTS WITH CHRONIC CHOLESTATIC HEPATITIS | 2000 |
|
RU2175869C1 |
| PREPARATION FOR TREATING DUODENAL ULCEROUS DISEASE AT HELICOBACTER ERADICATION | 2002 |
|
RU2225719C2 |
| AGENT FOR TREATMENT OF UROLITHIASIS | 2005 |
|
RU2281781C1 |
| MEDICATION FOR TREATMENT OF PATIENTS WITH DRUG HEPATITIS | 2009 |
|
RU2419449C1 |
| AGENT FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B | 2000 |
|
RU2180228C1 |
| AGENT FOR TREATMENT OF PATIENTS WITH HEPATITIS AND FIBROSIS SYMPTOMS | 2000 |
|
RU2164802C1 |
| MEDICATION FOR TREATING INTESTINAL DYSBIOSIS IN PATIENTS WITH CHRONIC CRYPTOGENIC HEPATITIS | 2009 |
|
RU2411955C1 |
| AGENT FOR TREATMENT OF LIVER CIRRHOSIS ACCOMPANYING WITH ASCITIS | 2001 |
|
RU2224532C2 |
